An investigational antibody-drug conjugate demonstrated clinically meaningful and durable responses in patients with platinum-resistant ovarian cancer, including patients whose tumors had low or no ...

AI-assisted scoping review of code sharing in clinical prediction model research. Publication: Nature Medicine. Dana-Farber Cancer Institute authors: ...

If you are a journalist and have a question about this story, please call 617-632-4090 and ask to speak to a member of the media team, or email media@dfci.harvard.edu.

Dana-Farber's Online Second Opinion Program for adult patients is powered by AccessHope. Once materials collection is complete, it typically takes 7 to 14 business days to receive your written online ...

What Is Soft Tissue Sarcoma? Soft tissue sarcoma refers to cancer that begins in the muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body. The tumors can be found ...

The Multiple Myeloma Program within the Hematologic Oncology Treatment Center includes physicians, clinicians, and research scientists who work together on promising new therapies. Your care team will ...

Dr. Barbie is the Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and a Professor of Medicine at Harvard Medical School. He is also Associate Director of the Belfer ...

Dr. Lakshmi Nayak serves as Director of the Center for CNS Lymphoma at Dana-Farber Cancer Institute in Boston. She is an Associate Professor of Neurology at Harvard Medical School. She received her ...

Our physician portal, Physician Gateway, helps you keep track of patients you have referred to Dana-Farber Brigham Cancer Center for care. Physician Gateway is available for primary care providers, ...

The primary purpose of the study is to determine the efficacy of an investigational therapy called DCVax(R)-L in patients with newly diagnosed GBM for whom surgery is indicated. Patients must enter ...

Our Center for Esophageal and Gastric Cancer includes medical, surgical, and radiation oncologists, gastroenterologists, radiologists, and pathologists who improve the outcome for patients with ...